Inactief instrument

Koers Oncothyreon Inc (USA) Nasdaq

Aandelen

Duur

Periode

Stijl

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04-01-18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02-01-18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13-12-17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07-12-17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08-11-17

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	+20,03%	126 mld.
REGENERON PHARMACEUTICALS, INC.	+23,61%	118 mld.
ARGENX SE	+23,26%	27,87 mld.
BIONTECH SE	-18,07%	20,95 mld.
GENMAB A/S	-15,13%	16,92 mld.
BEIGENE, LTD.	-14,81%	16,18 mld.
NEUROCRINE BIOSCIENCES, INC.	+9,78%	14,84 mld.
WUXI APPTEC CO., LTD.	-46,10%	14,79 mld.
SAREPTA THERAPEUTICS, INC.	+52,34%	14,08 mld.